This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $55.47, marking a -0.84% move from the previous day.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $57.44, marking a -0.19% move from the previous day.
ETFs to Shine as Trump Tosses Drug Rebate Curb Plan
by Sweta Jaiswal, FRM
We study the impact of Trump's dropping of the proposed drug rebate rule on some health ETFs with exposure to pharmacy benefit managers and healthcare insurers.
The Zacks Analyst Blog Highlights: DaVita, Fresenius, Baxter, Amgen and CVS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: DaVita, Fresenius, Baxter, Amgen and CVS
Stock Market News for Jul 12, 2019
by Zacks Equity Research
The Dow and S&P 500 closed at record highs on Thursday riding a rally among healthcare shares and Fed???s indication of an easier monetary policy.
Trump Drops Drug Rebate Proposal: What's Next and What Stocks to Play
by Christopher Vargas
The Trump administration announced Thursday that it's deciding to withdraw its proposal to eliminate rebates from government drug plans.
Can CVS Health (CVS) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Trump's Order on Kidney Care Lifts These Dialysis Stocks
by Tirthankar Chakraborty
Dialysis stocks move north after Trump signs an executive order designed to reform the nation's kidney treatment industry.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $54.83 in the latest trading session, marking a -0.87% move from the prior day.
CVS Health Banks on Aetna Prospects, Omnicare May Disappoint
by Zacks Equity Research
CVS Health's (CVS) Aetna integration synergies bode well for the stock.
Here's Why CVS Health (CVS) Should Be in Your Portfolio
by Zacks Equity Research
Investors' trust continues to be high in CVS Health (CVS), thanks to strength in its PBM business.
Top Analyst Reports: Mastercard, Coca-Cola, Amgen & More
by Kalyan Nandy
Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Coca-Cola (KO) and Amgen (AMGN).
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $54.80, marking a -0.24% move from the previous day.
Is Deep Value ETF (DVP) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DVP
Will Amazon (AMZN) be Rite-Aid's (RAD) Bandage?
by Mitchell Moore
Rite Aid Corporation (RAD) posted its Q1 2020 earnings results on Wednesday, June 26, after market close. This report was disappointing with an adjusted loss of -$0.14 per share, a steep dive from our zacks Consensus Estimate of +$0.02.
The Zacks Analyst Blog Highlights: Merck, Tractor Supply, IDEXX and CVS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Merck, Tractor Supply, IDEXX and CVS
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $53.70, marking a +0.04% move from the previous day.
4 Stocks to Make the Most of the Growing Love for Pets
by Tirthankar Chakraborty
With the U.S. pet industry poised to grow 3.9% to a record $75.4 billion this year, here are few stocks that could gain from the growing love for animals.
Tenet Healthcare Inks Deal to Offer Quality Health Services
by Zacks Equity Research
Tenet Healthcare (THC) enters into a contract with Aetna owing to which the company's healthcare services can be availed by Aetna members.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $53.87 in the latest trading session, marking a -1.86% move from the prior day.
Is Deep Value ETF (DVP) a Strong ETF Right Now?
by Sweta Killa
Smart Beta ETF report for DVP
Do Hemp Stocks Stand to Gain From a Weed-Liberal Illinois?
by Nitish Marwah
The marijuana legislation in Illinois would allow any resident of the state above the age of 21 to possess the novelty item.
The Geo Group, Vista Outdoor, CVS and Walgreens Boots Alliance highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
The Geo Group, Vista Outdoor, CVS and Walgreens Boots Alliance highlighted as Zacks Bull and Bear of the Day
Buy CVS Health (CVS) Stock After Optimistic Investor Day 2019?
by Zachary Stutler
CVS (CVS) stock jumped over 2% upon opening Tuesday morning and ended the day at $54.62, a 2.3% gain on the day. Confidence in the company???s future growth grew when it made multiple announcements regarding future earnings and projects at its investor day 2019 event.
CVS Health (CVS) Down 7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.